Tiemann Investment Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.32M | Sell |
9,227
-330
| -3% | -$71K | 0.84% | 26 |
|
|
2026
Q1 | $2.08M | Sell |
9,557
-500
| -5% | -$111K | 0.82% | 25 |
|
|
2025
Q4 | $2.3M | Sell |
10,057
-116
| -1% | -$26.4K | 0.89% | 22 |
|
|
2025
Q3 | $2.36M | Sell |
10,173
-157
| -2% | -$32K | 0.9% | 21 |
|
|
2025
Q2 | $1.92M | Sell |
10,330
-235
| -2% | -$43.7K | 0.79% | 24 |
|
|
2025
Q1 | $2.21M | Sell |
10,565
-95
| -0.9% | -$18.5K | 1% | 21 |
|
|
2024
Q4 | $1.89M | Sell |
10,660
-301
| -3% | -$55.3K | 0.84% | 23 |
|
|
2024
Q3 | $2.16M | Sell |
10,961
-175
| -2% | -$32.7K | 0.93% | 21 |
|
|
2024
Q2 | $1.91M | Hold |
11,136
| – | – | 0.85% | 23 |
|
|
2024
Q1 | $2.03M | Buy |
11,136
+120
| +1% | +$20.7K | 0.91% | 24 |
|
|
2023
Q4 | $1.71M | Sell |
11,016
-315
| -3% | -$45.9K | 0.83% | 30 |
|
|
2023
Q3 | $1.69M | Buy |
11,331
+50
| +0.4% | +$7.34K | 0.9% | 24 |
|
|
2023
Q2 | $1.52M | Sell |
11,281
-175
| -2% | -$25.7K | 0.77% | 33 |
|
|
2023
Q1 | $1.83M | Sell |
11,456
-216
| -2% | -$33K | 1% | 19 |
|
|
2022
Q4 | $1.89M | Sell |
11,672
-52
| -0.4% | -$7.97K | 1.11% | 16 |
|
|
2022
Q3 | $1.57M | Sell |
11,724
-4,800
| -29% | -$689K | 1.02% | 22 |
|
|
2022
Q2 | $2.53M | Sell |
16,524
-40
| -0.2% | -$6.11K | 1.35% | 15 |
|
|
2022
Q1 | $2.69M | Sell |
16,564
-165
| -1% | -$24K | 1.24% | 16 |
|
|
2021
Q4 | $2.27M | Buy |
16,729
+79
| +0.5% | +$9.33K | 0.96% | 21 |
|
|
2021
Q3 | $1.8M | Sell |
16,650
-256
| -2% | -$29.3K | 0.85% | 25 |
|
|
2021
Q2 | $1.9M | Sell |
16,906
-150
| -0.9% | -$16.9K | 0.89% | 23 |
|
|
2021
Q1 | $1.85M | Buy |
17,056
+1,237
| +8% | +$132K | 0.92% | 23 |
|
|
2020
Q4 | $1.7M | Buy |
15,819
+1,178
| +8% | +$113K | 0.9% | 25 |
|
|
2020
Q3 | $1.28M | Sell |
14,641
-274
| -2% | -$25.8K | 0.79% | 32 |
|
|
2020
Q2 | $1.46M | Buy |
14,915
+258
| +2% | +$22.7K | 1% | 23 |
|
|
2020
Q1 | $1.12M | Sell |
14,657
-225
| -2% | -$19.2K | 0.97% | 27 |
|
|
2019
Q4 | $1.32M | Sell |
14,882
-250
| -2% | -$20.8K | 0.9% | 28 |
|
|
2019
Q3 | $1.15M | Sell |
15,132
-933
| -6% | -$64K | 0.83% | 33 |
|
|
2019
Q2 | $1.17M | Sell |
16,065
-400
| -2% | -$31.4K | 0.85% | 32 |
|
|
2019
Q1 | $1.33M | Hold |
16,465
| – | – | 1.01% | 30 |
|
|
2018
Q4 | $1.52M | Buy |
16,465
+256
| +2% | +$22.5K | 1.36% | 13 |
|
|
2018
Q3 | $1.53M | Buy |
16,209
+3
| +0% | +$284 | 1.16% | 21 |
|
|
2018
Q2 | $1.5M | Sell |
16,206
-425
| -3% | -$41.5K | 1.2% | 20 |
|
|
2018
Q1 | $1.57M | Buy |
16,631
+325
| +2% | +$35.7K | 1.27% | 15 |
|
|
2017
Q4 | $1.58M | Sell |
16,306
-750
| -4% | -$70.7K | 1.26% | 19 |
|
|
2017
Q3 | $1.52M | Hold |
17,056
| – | – | 1.28% | 19 |
|
|
2017
Q2 | $1.24M | Buy |
17,056
+202
| +1% | +$13.6K | 1.11% | 25 |
|
|
2017
Q1 | $1.1M | Sell |
16,854
-250
| -1% | -$15.7K | 1.02% | 26 |
|
|
2016
Q4 | $1.07M | Sell |
17,104
-100
| -0.6% | -$6.1K | 1.05% | 25 |
|
|
2016
Q3 | $1.08M | Buy |
17,204
+200
| +1% | +$12.9K | 0.99% | 24 |
|
|
2016
Q2 | $1.05M | Sell |
17,004
-400
| -2% | -$24.4K | 0.99% | 27 |
|
|
2016
Q1 | $994K | Buy |
17,404
+100
| +0.6% | +$5.57K | 0.98% | 29 |
|
|
2015
Q4 | $1.02M | Sell |
17,304
-725
| -4% | -$41.8K | 1.04% | 23 |
|
|
2015
Q3 | $981K | Hold |
18,029
| – | – | 1.07% | 22 |
|
|
2015
Q2 | $1.21M | Buy |
18,029
+150
| +0.8% | +$9.79K | 1.24% | 17 |
|
|
2015
Q1 | $1.05M | Sell |
17,879
-350
| -2% | -$21.1K | 1.09% | 20 |
|
|
2014
Q4 | $1.19M | Sell |
18,229
-130
| -0.7% | -$8.2K | 1.28% | 16 |
|
|
2014
Q3 | $1.06M | Buy |
18,359
+175
| +1% | +$9.72K | 1.18% | 19 |
|
|
2014
Q2 | $1.03M | Sell |
18,184
-445
| -2% | -$23.3K | 1.14% | 19 |
|
|
2014
Q1 | $958K | Hold |
18,629
| – | – | 1.07% | 23 |
|
|
2013
Q4 | $984K | Buy |
+18,629
| New | +$916K | 1.16% | 22 |
|
Other funds holding ABBV
Tiemann Investment Advisors's ABBV Position: Q2 2026 in Review
Tiemann Investment Advisors reduced its AbbVie (ABBV) stake by 3.5% in Q2 2026, selling an estimated $71K and leaving 9,227 shares worth $2.32M. The position accounts for 0.84% of the portfolio, ranked #26.
Tiemann Investment Advisors first reported a position in ABBV in Q4 2013 and has held it in 51 quarters since. The position peaked at $2.69M in Q1 2022. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Tiemann Investment Advisors held 9,227 shares of AbbVie worth $2.32M as of Q2 2026.
- Tiemann Investment Advisors sold 330 AbbVie shares in Q2 2026, an estimated $71K.
- AbbVie made up 0.84% of Tiemann Investment Advisors's portfolio in Q2 2026, its #26 holding.
- Tiemann Investment Advisors first reported a position in AbbVie in Q4 2013 and has held it in 51 quarters since.
- Tiemann Investment Advisors's AbbVie position peaked at $2.69M in Q1 2022.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Tiemann Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.